According to MarketsandMarkets™, the global Infusion Pump market is projected to grow from USD 19.9 billion in 2025 to USD 28.3 billion by 2030, registering a CAGR of 7.4% during the forecast period. Market growth is being driven by rapid technological advancements, evolving healthcare delivery models, and the rising prevalence of chronic diseases.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506
Browse 608 market data Tables and 86 Figures spread through 582 Pages and in-depth TOC on “Infusion Pump Market”.
The emergence of advanced, interconnected infusion systems is transforming clinical workflows. Modern infusion pumps are increasingly integrated with electronic health records (EHRs) and hospital IT systems, enabling precise dosing, real-time monitoring, and enhanced clinical decision-making. These innovations are significantly improving patient safety and operational efficiency across healthcare settings.
Additionally, regulatory bodies worldwide are strengthening safety and cybersecurity standards for infusion pumps to reduce medication errors and address growing digital risks. This regulatory emphasis is further accelerating the adoption of advanced infusion technologies.
A major trend shaping the market is the shift from hospital-based care to home healthcare settings. Patients with chronic conditions such as diabetes, cancer, cardiovascular diseases, and autoimmune disorders are increasingly opting for home-based infusion therapies. This trend is further supported by the growing global geriatric population and the need for long-term, patient-centric care solutions.
Accessories & Consumables Segment Leads Market
By product, the accessories & consumables segment accounted for the largest market share in 2024. This dominance is driven by the recurring need for disposable components such as infusion sets, catheters, tubing, and connectors, which are essential for safe and effective drug delivery.
The frequent replacement of these single-use items to prevent infections and ensure treatment accuracy creates sustained demand. Increasing use of infusion pumps across hospitals, ambulatory care centers, and home care settings further strengthens the growth of this segment.
Diabetes Management Segment to Witness Fastest Growth
By application, the diabetes management segment is expected to register the highest CAGR during the forecast period. The rising global prevalence of diabetes, coupled with advancements in insulin pump technologies, is driving this growth.
Innovations such as hybrid closed-loop systems—also known as artificial pancreas systems—combine continuous glucose monitoring (CGM) with automated insulin delivery, enabling real-time dose adjustments. Enhanced features such as touchscreen interfaces, customizable insulin delivery, and mobile app integration are improving patient adherence and outcomes.
Lifestyle changes, aging populations, and increasing incidence of diabetes worldwide continue to fuel demand for advanced insulin infusion systems.
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=90374506
North America Dominates the Market
North America accounted for the largest share of the infusion pump market in 2024, driven by high healthcare spending, advanced infrastructure, and strong adoption of innovative medical technologies.
The region benefits from a well-established healthcare ecosystem, including a vast network of hospitals and outpatient facilities equipped with advanced infusion systems. Major industry players such as Becton, Dickinson and Company (BD), Baxter, and ICU Medical are headquartered in the region, contributing to continuous innovation and market expansion.
Rising prevalence of chronic diseases and an expanding geriatric population further support the demand for infusion pump systems, reinforcing North America’s leadership in the global market.
Competitive Landscape
Key players operating in the infusion pump market include Becton, Dickinson and Company (US), Baxter (US), B. Braun SE (Germany), ICU Medical, Inc. (US), Fresenius Kabi AG (Germany), Medtronic (Ireland), Terumo Corporation (Japan), NIPRO (Japan), AVNS (US), and Insulet Corporation (US).
These companies are focusing on product innovation, digital integration, and strategic collaborations to strengthen their market position and address the growing demand for safe and efficient infusion therapy solutions.
Related Reports:
Pharmaceutical Drug Delivery Market– Global Forecast to 2031
Insulin Delivery Devices Market – Global Forecast to 2030
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Rohan SalgarkarEmail: Send EmailPhone: 18886006441Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445City: FloridaState: FloridaCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/infusion-pumps-accessories-market-90374506.html
